Tirzepatide and lifestyle study for weight loss
Part of Hormones & metabolism, Mental health clinical trials.
This trial compares two ways to manage weight: taking a GLP-1 medication (like tirzepatide or semaglutide) versus making lifestyle changes without medication. It will help researchers learn which approach works best for people with overweight or obesity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your body mass index (BMI) is 27.5 or higher.
- For one group: You are starting a GLP-1 medication (like tirzepatide or semaglutide) for weight loss as prescribed by your doctor.
- For another group: You have not taken any weight loss medication in the past 3 months.
- You do not have a pacemaker or other implanted medical device.
- You do not have chronic kidney disease, active cancer, or certain other serious health conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medicine called tirzepatide, given as an injection, to see if it can improve daily function and symptoms in people with a weak heart (heart failure with reduced ejection fraction) who also have obesity. Tirzepatide works on two natural hormones to help with weight and may also improve heart health.
This trial looks at how two weight-loss medications, semaglutide and tirzepatide, affect your body's fat and muscle. It may help you understand if these medications improve your overall health beyond just weight loss.
This study tests if tirzepatide helps people with obesity lose weight, whether or not they have type 2 diabetes. It aims to see how safe and effective the drug is.
This study compares how a GLP-1 medication (a drug that helps control blood sugar and weight) changes the way your body stores and uses fat. Researchers will use imaging scans to see these changes over time in people with metabolic syndrome—a cluster of health conditions including high blood pressure, high cholesterol, and excess weight.
This trial tests two different weight-loss medications (semaglutide and tirzepatide) taken alongside exercise to help people with obesity. It aims to see which approach works better for weight loss and overall health.
This trial tests the safety and effectiveness of tirzepatide, a once-weekly injection, for weight loss in people with obesity. It might be an option if you have a BMI of 27 or higher with weight-related health problems, or a BMI of 35 or higher, and live in or near Asunción, Paraguay.
Hear when a new Obesity & Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.